Eikermann-Haerter K., Dileköz E., Kudo C., et al. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest 119 (2009) 99-109
Silberstein S.D., Schoenen J., Göbel H., et al. Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine. Cephalalgia 29 suppl 2 (2009) 17-27
Hauge A.W., Asghar M.S., Schytz H.W., Christensen K., and Olesen J. Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study. Lancet Neurol 8 (2009) 718-723
Hashemi P., Bhatia R., Nakamura H., et al. Persisting depletion of brain glucose following cortical spreading depression, despite apparent hyperaemia: evidence for risk of an adverse effect of Leão's spreading depression. J Cereb Blood Flow Metab 29 (2009) 166-175
Piilgaard H., and Lauritzen M. Persistent increase in oxygen consumption and impaired neurovascular coupling after spreading depression in rat neocortex. J Cereb Blood Flow Metab 29 (2009) 1517-1527
Kruit M.C., van Buchem M.A., Hofman P.A., et al. Migraine as a risk factor for subclinical brain lesions. JAMA 291 (2004) 427-434
Scher A.I., Gudmundsson L.S., Sigurdsson S., et al. Migraine headache in middle age and late-life brain infarcts. JAMA 301 (2009) 2563-2570
Schürks M., Rist P.M., Bigal M.E., Buring J.E., Lipton R.B., and Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 339 (2009) b3914
